Catheter Precision, Inc. (VTAK)

Market Cap	2.64M
Revenue (ttm)	399,000
Net Income (ttm)	-11.68M
Shares Out	8.00M
EPS (ttm)	-10.96
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	232,115
Open	0.311
Previous Close	0.327
Day's Range	0.311 - 0.368
52-Week Range	0.310 - 4.100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About VTAK

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removi...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 30, 2018
• Employees: 14
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: VTAK
• Website: https://www.catheterprecision.com

Financial Performance

In 2023, Catheter Precision's revenue was $442,000, an increase of 3057.14% compared to the previous year's $14,000. Losses were -$71.37 million, 165.7% more than in 2022.